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In developing limb buds, Msx2 transcripts are expressed in the apical ectodermal ridge (AER) and in various regions of the limb
mesenchyme. To identify DNA sequences responsible for Msx2 expression in the AER, we characterized the expression of LacZ reporter
constructs driven by chicken Msx2 regulatory sequences in transgenic mice. We have identified a 55-bp enhancer that can direct AER-
specific reporter gene expression. This 55-bp enhancer contains three elements that are evolutionary conserved among five vertebrate Msx2
genomic sequences. AER expression of reporter constructs in transgenic mice is lost or reduced when mutations are introduced into each of
these three regions. Moreover, changing the relative orientation by reverse complementing one of the three elements also results in loss of
expression, suggesting that the relative orientations of transcription factor binding is important. To identify the transcription factor(s) binding
to these elements, we conducted one-hybrid screening and identified Dlx5 and Sox11. Both Dlx5 and Sox11 are expressed in the AER, and
the proteins encoded by these genes bind to separate conserved elements, supporting their possible roles in regulating Msx2 expression.
D 2004 Elsevier Inc. All rights reserved.Keywords: Msx2; Apical ectodermal ridge; Dlx5; Sox11; Enhancer; Gene regulation; Limb development; Transgenic miceIntroduction
The apical ectodermal ridge (AER) is a critical organi-
zing center that regulates the outgrowth and patterning of
the developing vertebrate limb (Capdevila and Izpisu´a
Belmonte, 2001). Msx2, a homeodomain containing tran-
scription factor, is expressed in the AER and other regions
of the developing limb in temporally and spatially specific
patterns (Liu et al., 1994; Sumoy et al., 1995). The expres-
sion pattern of Msx2 mRNA in a variety of tissues as well as
the effects of forced expression and knockout experiments
suggest a possible role for Msx2 in cell death that may
involve BMPs (Marazzi et al., 1997; Trousse et al., 2001).
Forced expression of Msx2 in developing limb buds leads to
ectopic apoptosis and limb truncation supporting its func-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.03.005
* Corresponding author. Department of BioStructure and Function,
School of Dental Medicine, University of Connecticut Health Center, 263
Farmington Avenue, Farmington, CT 06030-3705. Fax: +1-860-679-2910.
E-mail address: upholt@nso2.uchc.edu (W.B. Upholt).tion in regulating apoptosis (Ferrari et al., 1998). Mice in
which Msx1, or Msx2, have been inactivated developed
normal limbs whereas mice with double knockouts of both
Msx1 and Msx2 develop abnormal limbs suggesting redun-
dancy or compensation in the function of these transcription
factors in the AER (Houzelstein et al., 1997; Satokata and
Maas, 1994; Satokata et al., 2000).
Sumoy et al. (1995) and Liu et al. (1994) have identified
regions of the chicken and mouse Msx2 genes that can drive
expression of reporter genes specifically to the AER. These
regulatory regions have proved to be very useful as tools to
specifically express or inactivate a variety of genes within
the AER to better understand their function in the AER (Guo
et al., 2003; Robledo et al., 2002; Sun et al., 2000).
Some genes, including Msx2, Fgf4, Fgf8, Dlx genes, and
Bmp genes have highly localized expression patterns in the
AER (Capdevila and Izpisu´a Belmonte, 2001). Many of the
products of these genes appear to participate in complex
gene regulatory networks that control proper limb forma-
tion, as well as the proper formation of some other tissues
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et al., 2000; Johnston and Bronsky, 1995; Kulessa et al.,
2000; Newberry et al., 1998; Rifas et al., 1997; Satokata
et al., 2000; Tanaka et al., 1999). As our knowledge of the
regulation of gene transcription expands, it is becoming
increasingly clear that individual genes are regulated by
complexes of factors interacting with regulatory elements
consisting of multiple binding sites. To facilitate the under-
standing of these regulatory networks and to further under-
stand the regulation of Msx2, we have taken several
approaches to define specific regulatory elements in the
Msx2 gene and to identify transacting factors expressed in
the AER that can interact with these regulatory elements.
We have characterized Msx2 regulation by evolutionary
DNA sequence comparisons, analysis of Msx2 enhancer/
reporter constructs in transgenic mice and in transfected
cultured cells, DNA electrophoretic mobility shift analysis
with nuclear extracts and purified proteins, yeast one-hybrid
screening, and analysis of gene expression by reverse
transcriptase PCR and in situ hybridization. From these
studies, we have identified three elements within a 55-bp
fragment that are important for AER expression and have
identified Dlx5 and Sox11 transcription factors as possible
regulators of Msx2 expression in the AER through two of
these elements.Materials and methods
Generation and analysis of transgenic mouse embryos
Constructs used in this study are shown in Figs. 1 and 2
and contain various 5V regions of the chicken Msx2 gene.
Constructs #1 and #2 in this work are the same as constructs
#6 and #8 in Sumoy et al. (1995). Construct #3 contains
tetrameric repeats of a 361-bp BglII to HpaII fragment
(841 to 480). Nucleotide positions are relative to the
translation start site and are indicated in Fig. 1. RegulatoryFig. 1. A 55-bp region of the chicken Msx2 genomic sequence directs reporter g
chicken Msx2 genomic sequence used to generate transgenic constructs #1 to #7. T
site is shown to the left of construct numbers, and the total number of transgenic
showing expression in the AER are shown to the right. The gray boxes on each
highlighted as shaded boxes in (C). The blue boxes in A and construct #17 indicate
#1 and #2 (marked with asterisks) are from the publication of Sumoy et al. (1995).
sequence. A 306-bp fragment, containing the entire 55-bp AER enhancer and flank
sequence (517 to 378) to the corresponding sequences from human (AC117531
bp fragment, mammalian sequences show over 93% identity, while the chicken
containing at least six contiguous nucleotides identical in all four species are highl
homeodomain binding core sequences previously identified by Sumoy et al. (19
posterior portions of the AERs of the forelimbs. (E, G, H) Forelimbs and hindlimbs
constructs 8 and 9). (E, G) Limb buds of embryos of constructs #7 and #8 show con
#8, the h-gal staining is also observed in the central condensing cartilage because c
1995). Construct #8 and all subsequent constructs (described in Fig. 2) contain th
construct #9 showed h-gal staining in the condensing cartilage, but not in the AE
enhancer that disrupts its function. (F) Cross section of a limb bud of an embryo w
the conserved region removed is still expressed in the AER.sequences in constructs #4 (841 to 535) and #5 (624
to 438) were generated by PCR with restriction sites
added to the primers for making the tandem repeats.
Construct #6 was generated by PCR based ligation of two
smaller PCR fragments to remove conserved element I. For
constructs #7 to #16, overlapping oligonucleotides were
annealed, filled in, and cloned. All PCR products were
sequenced before cloning into transgenic vector phsnlacF
(Sumoy et al., 1995). For constructs #6 and #8 to #16,
tetrameric repeats of a 182-bp Col2 enhancer (Zhou et al.,
1995) were cloned 5V to the Msx2 sequences. Construct #17
contains an additional 5.1 kb of 5V Msx2 sequence com-
pared to construct #1 and was made in vector pnlacF.
Construct #18 is the same as construct #17, with the
exception that a 306-bp region spanning the conserved
region was deleted. One-cell FVB/NJ embryos were used
for making transient transgenic embryos (Hogan et al.,
1994). Embryos were collected on E11.5 and stained for
h-galactosidase activity as described in Sumoy et al. (1995).
Embryos were genotyped by Southern hybridization or
PCR against the lacZ sequence in phsnlacF using genomic
DNA obtained from placental tissues (Hogan et al., 1994).
Electrophoretic mobility shift assays
Limb tips including the entire AER and as little mesen-
chyme as possible were dissected from stage 22 to 23 chick
limbs. Whole-cell extract was prepared as described by
Charite´ et al. (1998). Chicken Dlx5 and Sox11 cDNAs
obtained in the one-hybrid screening described below were
cloned in pcDNA3.1 expression vector (Invitrogen) for in
vitro translation using the TNT Quick Coupled Transcrip-
tion/Translation System (Promega). Oligos were annealed to
their complements to form the double-stranded DNA probes
(see Fig. 3D for sequences) and labeled with g-32P ATP
using T4 kinase. After incubation at 0jC for 30 min, the
electrophoretic mobility shift assay (EMSA) mixture was
loaded onto the gel.ene expression to the AERs of transgenic mouse embryos. (A) Regions of
he exact nucleotide position of each construct relative to the translation start
embryos obtained for each construct and the number of transgenic embryos
fragment indicate the positions of the four conserved regions that are also
the position of the conserved sequence shown in C. The data for constructs
(B) Constructs #17 and #18 contain 5.9 and 5.6 kb of chickenMsx2 genomic
ing sequences, was removed in construct #18. (C) Alignment of the chicken
), dog (AJ303104), mouse (S60698), and rat (AABR03105093). In this 140-
sequence shows 73% identity to other mammalian sequences. The regions
ighted with shaded boxes and numbered as I, II, III, and IV. The five TAAT
95) are underlined. (D) Construct #3 is expressed only in the anterior and
of embryos carrying constructs #7, #8, and #9 (see Fig. 2 for description of
tinuous h-gal staining along the AER. In limb buds of embryos of construct
onstruct #8 also contains a tetramer of a 182-bp Col2 enhancer (Zhou et al.,
e Col2 cartilage enhancer as an internal positive control. (H) The limbs of
R as the Msx2 enhancer in construct #9 bears a point mutation in the AER
ith construct #7 showing h-gal staining in the AER. (I) Construct #18 with
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Three bait sequences, containing tetrameric repeats of
element I, element III, or the entire 55-bp AER enhancer
H.-C. Cheng et al. / Developmfragment, were cloned into pHISi, pHISi-1, and pLacZi
yeast integration and reporter vectors (Clontech). Yeast
reporter strains used for one-hybrid screening were made
by integrating reporter plasmids into the chromosome of
Fig. 2. Frequency of AER transgene expression in transgenic mouse embryos containing constructs with modifications of the 55-bp AER enhancer region. In
addition to tetrameric repeats of the 55-bpMsx2 sequence, all constructs carry four tandem repeats of the Col2 enhancer at the 5V end included in the constructs
as an internal positive control for promoter/reporter function of the transgene. The three conserved regions are highlighted by the shaded regions, and the
mutated nucleotides as well as the gaps in the human (#13) and mouse (#14) sequences compared with the chicken sequence are boxed. The numbers on top of
the sequence indicate the position of the sequence relative to the translation start site. Constructs #9 and #10 contain point mutations in elements I and III,
respectively. Construct #11 contains four nucleotide changes in element II. Construct #12 contains an inverted element III. Constructs #13 and #14 contain the
corresponding regions of human (#13) and mouse (#14) Msx2 genes. Construct #15 contains three nucleotide changes to convert the sequence of element III to
the reverse, complementary sequence of element I. In construct #16, element I is similarly converted to element III.
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made and screened following the MATCHMAKERk Lib-
rary Construction and Screening Kit manual (Clontech)
with 1 Ag of total RNA isolated from stage 22/23 chick
limb peripheral epithelium including the AER for each
screening. The yeast transformants were plated onto
HIS/LEU/15 mM 3-AT plates for screening. One micro-
liter of yeast transformants was plated on LEU plate for
transformation efficiency estimation. The expression pat-
terns of candidate clones were detected by in situ hybridi-
zation performed as described in Ferrari et al. (1995).
Cell culture, transient transfection assays, and reporter
gene assays
The reporter plasmid pGL3-AER was made by cloning
the 55-bp Msx2 sequence into pGL3-basic (Promega).
pEGFP, which has the same CMV promoter as the
pcDNA-Sox11 and pcDNA-Dlx5 expression constructs,
was used to equalize for various amounts of Sox11 and
Dlx5 expression vectors transfected. HeLa cells and COS-7
cells were grown in DMEM medium (Invitrogen) supple-
mented with 10% fetal bovine serum and antibiotics. For
transient transfections, Lipofectamink and Plusk reagent
(Invitrogen) were used following manufacture’s instruc-
tions. pRL-CMV (1 ng) (Invitrogen) was cotransfected
and its activity was later used as internal control for
normalization of the reporter activity of pGL3-AER. Thir-
ty-six hours after transfection, the cells were harvested, and
Firefly and Renilla luciferase activities were measured in
5 Al of the cell lysate by the dual luciferase assay (Promega)
using a Moonlight 2001k luminometer (Analytical Lumi-
nescence Laboratories).Results
Identification of a 55-bp AER enhancer in the chicken Msx2
gene
Previously, an 806-bp region of the chicken Msx2 gene
was identified, which functions efficiently as an apical
ectodermal ridge (AER) enhancer in transgenic mice
(Sumoy et al., 1995) (Fig. 1A, construct #1). In the same
report, a smaller 348-bp region containing four potential
homeodomain binding sites (Fig. 1A, construct #2) was also
shown to be sufficient for AER expression, but only 10% of
the transgenic embryos carrying the construct expressed the
reporter in the AER (Sumoy et al., 1995). The low frequen-
cy of transgene expression in the AER in embryos with
construct #2 suggested that the regions removed contain
important enhancer elements for AER expression. To test for
the presence of AER regulatory elements in the 5V 361-bp
region removed from construct #2, a tetrameric tandem
repeat of this region was used to generate construct #3.
We chose to use a tetramer rather than a monomer based on
published reports that multimers of relatively small enhancer
elements often function more effectively than monomers
(Ghosh et al., 1993). Construct #3 drives lacZ expression in
the AER in 4/6 transgenic embryos, similar to the expres-
sion frequency of construct #1. Although expressing mice
were obtained at relatively high frequency, the h-gal stain-
ing in embryos of construct #3 was absent from the central
region of the AER and was limited to the anterior and
posterior regions of the AER (Fig. 1D). These combined
results suggest that although either the 361-bp region or the
348-bp region alone is sufficient for AER expression,
enhancer elements residing in these two regions cooperate
Fig. 3. Electrophoretic mobility shift assays of the AER enhancer region using AER-enriched distal limb nuclear extract or in vitro translated Dlx5 or Sox11
proteins. (A) Electrophoretic mobility shift assay with nuclear extract prepared from limb distal epithelium and 32P-labeled oligonucleotides containing native
or modified sequences of the AER enhancer. Open arrowheads mark bands that are present with the native sequences but not with the modified
oligonucleotides. (B and C) EMSA using oligonucleotide probes I and IIIs with Dlx5 (B) or Sox11 (C) products from the Promega coupled transcription/
translation system. Five or 50-fold excesses of oligonucleotides I, mI, IIIs, or mIIIs were used as competitors. Mutations in oligos mI and mIII were designed to
eliminate binding of homeodomain proteins to these elements. The mutation in mIIIs is designed to eliminate Sox binding to element III. Luc protein in B is a
control transcription/translation reaction using the Luciferase T7 control DNA provided with the Promega TNT kit. (D) Sequences of the 55-bp AER enhancer
region and oligonucleotide probes and competitors used.
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Msx2 expression throughout the AER.
To understand the molecular mechanisms by which this
Msx2 enhancer directs reporter gene expression to the AER,
we further characterized the 806-bp fragment that gives
AER expression at high frequency. This 806-bp region of
the chicken gene was aligned and compared with the
corresponding regions of human, mouse, rat, and dog
Msx2 genes. Since the mammalian sequences are highly
conserved throughout evolution, we concentrated on those
sequence elements that are conserved between mammals
and the more evolutionary distant chicken, as regions
conserved between chicken and mammals are more likely
to be of regulatory importance. This comparison identified a
region of 140 bp with 73% identity between chicken and the
mammals and over 93% identity among the mammalian
species (Fig. 1C).We looked for highly conserved sequences within the
140-bp region that might serve as transcription factor
binding sites and identified four positions containing
stretches of six of more continuous nucleotides that are
identical among all five species examined. One region was
noticeably CT-rich, and the other three contained homeo-
domain binding sites with TAAT cores. We have named the
four conserved sites elements I to IV (see Fig. 1C).
Previously, Sumoy et al. (1995) compared the then available
chicken sequence and mouse Msx2 sequence and identified
five conserved TAAT sites (underlined in Fig. 1C). Three of
the five previously identified TAAT sites correspond to
conserved elements I, III, and IV, but the two other previ-
ously identified TAAT sites have mismatches flanking both
sides of the core TAAT sequence.
Pan et al. (2002) used the 806-bp region and introduced
point mutations to individually or jointly disrupt the func-
H.-C. Cheng et al. / Developmental518tion of the four TAAT sites present in the 348 bp of
construct #2 to study their roles in controlling Msx2
expression in the AER. Analysis of the resulting transgenic
mice showed that a single nucleotide mutation in the second
TAAT site (conserved element III of Fig. 1C) reduced the
frequency of AER expression in transgenic embryos from
57% to 14%, while similar mutations in the other three
TAAT sites, including element IV, had little affect on AER
expression frequency. These data indicate that element III is
critical for AER enhancer activity, and that the two less-
conserved TAAT sites, and also element IV, are either not
important or relatively unimportant for AER enhancer
activity.
Since construct #3 is able to drive AER expression and
also contains element I, but not the more proximal
conserved regions present in construct #2, we tested
whether element I might be responsible for the AER
expression of construct #3 by removing 55 nt including
element I from the 3V end of construct #3 to generate
construct #4. No h-gal staining was observed in the any of
the AERs of nine transgenic embryos carrying construct
#4 (data not shown). This result confirmed that element I
is important for AER expression. The combination of this
result with the results of Pan et al. (2002) indicates that
both elements I and III contribute to Msx2 AER enhancer
activity.
Since the distal 296 bp of the 361-bp fragment
showed less than 39% identity among all species ana-
lyzed and none of the nine transgenic embryos with
construct #4 showed AER expression, we hypothesized
that this region might not be required for expression of
Msx2 in the AER. Therefore, we removed the distal
nonconserved 216 bp of the 361-bp fragment. Since Pan
et al. (2002) previously demonstrated the importance of
conserved element III, we also included both conserved
elements II and III with the remaining proximal 145 bp
of the 361-bp fragment to make construct #5. Constructs
with tetrameric repeats of the combined 187-bp fragment
in construct #5 express the reporter in the AER in 100%
of transgenic embryos indicating it carries important
elements that are sufficient to drive robust reporter
expression in the AER. To further define a minimal
enhancer that can direct Msx2 expression to the AER,
we generated a 55-bp fragment that contains the minimal
number of nucleotides necessary to include conserved
elements I, II, and III. Although reporter constructs with
a single copy of the 55-bp fragment were not expressed
in the four embryos examined (data not shown), cons-
tructs containing tetrameric tandem repeats of this 55-bp
fragment (constructs #7 and #8) drove reporter expres-
sion to the AER in 17 out of 18 transgenic embryos
(Figs. 1E–G). These results indicate that this 55-bp
fragment, containing elements I, II, and III, when present
as tetrameric repeats, is sufficient to drive continuous
expression along the AER in a high percentage of
transgenic embryos.Three conserved elements are required for AER enhancer
activity
The cross-species DNA sequence comparisons, the trans-
genic mice analyses of constructs #2 to #7, and the point
mutation studies reported by Pan et al. (2002) all support the
hypothesis that conserved elements I and III containing
putative homeodomain binding sites are functional elements
in this 55-bp fragment. The high degree of DNA sequence
conservation of element II in all five species suggested that
this element also might be important for AER enhancer
activity.
To further test the importance of these three individual
elements in the 55-bp AER enhancer, we introduced
mutations to individually disrupt DNA–protein interac-
tions of each of the three conserved elements. We used
nucleotide replacement rather than nucleotide deletion to
avoid changing the spatial relationships among the con-
served elements, as this might interfere with protein–
protein interactions rather than only DNA–protein inter-
actions. It has been shown that mutating a single A to G
in the homeodomain binding site can disrupt homeodo-
main protein binding (Catron et al., 1993) and greatly
reduce AER enhancer activity (Pan et al., 2002). There-
fore, oligonucleotides containing A to G mutations in the
TAAT cores of either element I or III were synthesized
and used to generate transgenic constructs containing
tetramers of the 55-bp region. Based on analysis of the
55-bp region by Transcription Element Search System
(TESS; Petsko, 2002), region II matches consensus
binding sites for at least 12 known transcription factors.
We changed this conserved region from CTTTTC to
GTACTA, as analyses using TESS showed that changing
these four base pairs maximally disrupts matches to these
known consensus binding sequences. Since we predicted
that these mutations might cause loss of transgene
expression, to facilitate the analysis, a tetrameric repeat
of a 182-bp Col2 enhancer (Zhou et al., 1995) was
cloned next to the Msx2 enhancers to serve as an
internal control. The Col2 enhancer was chosen for its
high penetrance of expression and because it is expressed
in the limb at the same embryonic stage as Msx2 in a
pattern that is distinct from the AER expression of Msx2
and does not interfere with the analysis of Msx2-driven
reporter expression in the AER (Pan et al., 2002; Zhou
et al., 1995). Comparison of the h-gal expression pattern
in transgenic embryos of construct #7 and construct #8
(Figs. 1E, G) confirms that the Col2 enhancer and Msx2
enhancer are able to work independently in the same
construct. Transgenic embryos of constructs #9, #10, and
#11, which individually contain mutations in the core
sequences of each of the three conserved elements, showed
either no AER expression (construct #9, Fig. 1H) or AER
expression in only about 15% of embryos (constructs #10
and #11; Fig. 2). The loss of or reduction in the frequency of
AER expression following mutations in each of the three
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transcription factor binding sites and that the presence of
all three intact elements is critical for transgene expression in
the AER.
Since all three conserved elements within this 55-bp
enhancer are required for consistent AER enhancer activity,
it is possible that the transcription factors binding to these
three sites directly interact with each other forming a
complex. Such interactions are likely to be dependent or
appropriate spatial orientations of binding. As a test of the
importance of binding orientation, we changed the orienta-
tion of element III relative to elements I and II by replacing
region III with its reverse complement. This should result in
the transcription factor that binds to element III being on the
opposite side of the double helix and facing in the reversed
direction along the DNA. The absence of AER expression in
embryos carrying construct #12 (Fig. 2) suggests that that
element III may work cooperatively as a part of a complex
also binding to elements I and/or II.
The regions of the human and mouse Msx2 genes
corresponding to the 55-bp conserved region do not have
enhancer activity equivalent to that of the chicken gene
Although the 55-bp region we selected for analysis has a
high level of sequence conservation between the chicken
and mammalian sequences, there are significant differences
in the spacing of the three elements in the various species.
Between elements I and II, there are 12 nt in the chicken
versus 9 nt between the same elements in the mouse and
human. There are 12 nt between elements II and III in the
chicken, 11 nt in human, and 9 nt in mouse (see Figs. 1C
and 2). Since these differences lead to changes in the
relative positions of each element on the DNA axis, we
tested whether these differences have any effect on AER
enhancer activity. Constructs carrying tetramers of the
human or mouse sequence (constructs #13 and #14, respec-
tively) are expressed in the AER, but a significantly lower
frequency of embryos expresses the transgene in the AER
(Fig. 2). This reduced expression frequency with human or
mouse sequences suggests either (1) the exact spacing
between binding factors or the relative position of the
binding factors around the helical axis of the DNA is
important for interactions between regulatory factors or (2)
the nonconserved sequences between the sites are important
for AER enhancer activity.
Regions outside of the 55-bp region are also important for
high frequency expression of Msx2 in the AER
When present as a monomer, the chicken 55-bp region
is insufficient to drive high frequency expression in the
AER (0/4), and based on constructs containing larger
fragments of the chicken Msx2 gene, regions of the gene
5V of the 55-bp region are necessary for robust expression
of the reporter gene at high frequency in independentlyderived transgenic insertions of the transgene. A construct
with 806 bp of sequence upstream of the translation start
site (including the 55-bp AER enhancer region)
(construct #1) is expressed in the AERs of 57% (4/7) of
mice with independent transgene insertions whereas con-
struct #17 (Fig. 1B), with an additional 5.1 kb sequence
compared to construct #1, is expressed in 92% (11/12) of
independently derived transgenic animals. This finding
suggests that there are additional unidentified enhancer
elements in the 5.1 kb sequence that increase the AER
enhancer activity compared to the 806-bp region alone. The
existence of additional AER enhancer elements outside the
55-bp conserved region is also supported by our observa-
tion that a construct in which a 306-bp conserved region
that includes the 55-bp AER enhancer was removed from
the 5.1 kb sequence (construct #18 in Fig. 1B) still directed
reporter expression to the AER, although at low frequency
and only in a limited number of cells of the central region
of the AER (Fig. 1H). The low frequency of expression in
the AER with this construct also suggests that the con-
served region absent from construct #18 is essential for
robust expression of Msx2 in the AER.
AER-enriched nuclear extracts contain proteins that bind
specifically to the conserved regions
To define the nucleotides involved in binding to the
conserved regions, we performed electrophoretic mobility
shift assay (EMSA) experiments using AER-enriched pe-
ripheral limb nuclear extracts and labeled double-stranded
oligonucleotide probes corresponding to the sequences used
to generate transgenic constructs. Probe I is 35 bp in length
and includes elements I and II. It overlaps with the 34-bp
Probe III that contains element II and III. Complexes
generated by the binding of proteins to element I or III
were identified by comparing the gel-mobility shift patterns
of probes I and III with those obtained with probes mI and
mIII that are identical with the exception that they contain
the same single nucleotide mutations in elements I and III
that eliminated AER expression in transgenic mice (Figs. 2,
constructs #8 and #9, and 3D). Comparison of the gel shift
patterns with probes I and mI revealed two bands, which are
observed only with probe I but not present with probe mI
(Fig. 3A, left, open arrowheads). The specific loss of these
two complexes indicates that the binding of the transcription
factors in the nuclear extract to element I is sequence
specific. A similar experiment with probes III and mIII
revealed one DNA/protein complex that is specific to
element III (Fig. 3A right, open arrowhead). The DNA–
protein complexes specific for elements I and III are likely
to contain different proteins as their migration properties are
different (Fig. 3A). We also observed a faint band in the lane
with probe I migrating at the same position as the specific
complex with probe III and, with a longer exposure of the
EMSA gel with probe III (data not shown), two additional
bands migrating at the same positions as the two specific
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the similarity between elements I and III, suggest that the
main factor(s) binding to element I may also bind less
strongly to element III and vice versa. These differences
in binding strengths for the similarly migrating complexes
formed with probes I and III are also consistent with the
hypothesis that the predominant DNA–protein complexes
formed with the two probes are formed with different
proteins.
These results are consistent with our analysis of enhancer
activity in transgenic mice, as single point mutations in
elements I or III cause the loss of specific transcription
factor binding in EMSA, and the same mutations lead to
loss of reporter gene expression in the AERs of transgenic
embryos. In complementary experiments, we used two 24 nt
oligonucleotides, Is and IIIs, that contain only the core
sequences of elements I or III and minimal flanking
sequences for competition. The Is and IIIs oligos specifi-
cally compete for the binding of the factors and result in loss
of the bands described above (data not shown).
Isolation of transcription factors that bind to conserved
elements I and III
To understand the regulation and interaction of the AER
enhancer at the molecular level, we sought to identify the
transcription factors that bind to these conserved regions.
First we used EMSA oligo competition assays with com-
petitor oligonucleotides containing the consensus binding
sequences of various factors that, based on TESS analysis,
were predicted to bind to the 55-bp region. We have tested
oligonucleotides containing the consensus binding sites for
GATA, Oct, N-box, and E-box transcription factors, but
none of these have the same competition ability as that of
oligonucleotides Is or IIIs (data not shown). Based on these
results, we concluded that the factors binding to conserved
element I and III are unlikely to belong to the above
mentioned families.
We then did yeast one-hybrid screening with several
different subsequences of the 55-bp region as bait for
isolating transcription factors that are expressed in chick
limb epithelium and that can bind to the AER enhancer.
Because the fraction of total embryonic cells comprising the
AER is very small, and because the 55-bp enhancer is active
only in the AER of transgenic mice, we chose not to use the
commercially available mouse whole embryo library, but to
prepare our own library from total RNA purified from the
AER-enriched peripheral limb epithelium from stage 22 to
23 chicken embryos.
Conserved element I was used as bait to screen
approximately 2  106 colonies resulting in the isolation
of 16 independent clones. Four of these clones corres-
ponded to the known transcription factors, Dlx5, Tlx3,
and Shox2, with two independently isolated clones
corresponding to Dlx5. A combination of published
reports and our own in situ hybridization results showthat Tlx3 and Shox2 are expressed only in the proximal
region of the limb close to the trunk (Clement-Jones et
al., 2000; Qian et al., 2002; Shirasawa et al., 2000) and
data not shown), and therefore are not good candidates for
directing expression in the AER. From previous reports,
we know that Dlx5 is expressed in the distal part of
developing limb bud, including the AER (Ferrari et al.,
1995, 1999; Robledo et al., 2002). In addition, the
sequence of element I is an excellent match to the
reported Dlx consensus binding sequence, (A/C/G/)
TAATT (G/A) (C/G) (Feledy et al., 1999), further sup-
porting the possible role of Dlx5 in regulating Msx2
expression in the AER. Two independent clones contain-
ing Dlx5 cDNA sequences were isolated. To confirm that
Dlx5 can bind to conserved element I, we performed
EMSA analysis with in vitro translated Dlx5 protein and
oligo I showing a retarded band that was greatly reduced
by competition with 5-fold excess of unlabeled oligo,
fully competed by 50-fold excess of unlabeled oligo and
only partially competed by 50-fold excess of mI oligo
with a A!C mutation in the site. These results show that
Dlx5 binds specifically to element I.
We also screened approximate 1.5  106 colonies of the
fusion protein library using conserved region III as bait
resulting in the isolation of four clones containing the cDNA
for Sox11. Sequence analysis indicates that the four clones
are derived from at least three independent recombination
events. Sox11 is an HMG box containing protein of the
SRY-box containing transcription factors family (Wilson
and Koopman, 2002). Previous reports in the literature
show that Sox11 mRNA is expressed in the distal part of
mouse limb buds (Hargrave et al., 1997), and our in situ
hybridization in chicken limb bud (Fig. 4) shows that Sox11
is expressed in the AER.
Although a Sox11-specific DNA binding sequence has
not been empirically identified, Kuhlbrodt et al. (1998) have
successfully shown that Sox11 activates a Sox-responsive
luciferase reporter plasmid containing a multimerized Sox
binding motif, AACAAAG, which fits the consensus bin-
ding sequence reported for SRY (A/T)AACAA(T/A) (Har-
ley et al., 1994). In comparison of the consensus sequence to
the sequence of oligo III, we predicted that Sox11 binds to a
7 nt region extending 5V from and overlapping conserved
element III by 4 nt. Gel shifts with both in vitro translated
Sox11 and GST purified Sox11 HMG domain confirmed
that Sox11 binds to an oligo containing element III and that
an excess of unlabeled oligo, but not of an oligo with
mutations in the putative Sox11 binding site, competes for
binding (Fig. 3C).
Previous studies by Pan et al. (2002) showed that Dlx5
can bind weakly to conserved element III, and EMSA
experiments using Sox11 with element I (data not shown)
suggest the possibility that AER-specific expression might
be achieved by binding of either one Dlx5 and Sox11
factor, two Dlx5, or two Sox11 factors. Furthermore,
when 10 nt regions containing either element I or element
Fig. 5. Sox11 and Dlx5 can both activate reporter gene expression through
the 55-bp AER enhancer. Dlx5 and Sox11 expression vectors, pcDNA-
Sox11, and pcDNA-Dlx5 were cotransfected with the Msx2/firefly
luciferase construct pGL3-AER, which contains tetramers of the 55-bp
Msx2 enhancer upstream of the promoter. A constant amount of pRL-CMV
expressing Renilla luciferase was cotransfected and its activity was used as
internal control for normalization of the reporter activity of pGL3-AER.
Cotransfection of pcDNA-Sox11 or pcDNA-Dlx5 with the Msx2 reporter
construct elevated reporter gene expression two to threefold above basal
activity. The combination of both Dlx5 and Sox11 did not further enhancer/
reporter gene expression. Transfections were repeated three times.
Fig. 4. In situ hybridization analysis of Sox11 expression in the developing limb. (A) Sagittal section of a stage 24 limb bud, and (B) frontal section of stage 23
limb bud. Note Sox11 expression throughout the whole limb bud with stronger expression in the epithelium. Sox11 was detected using 33P-labeled chicken
Sox11 cDNA probe.
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are identical between these two elements. To test the
hypothesis that these two elements might have similar
functions in vivo, we generated two additional constructs
both containing three nucleotide changes, converting ele-
ment I to a reverse, complementary element III (construct
#15) or converting element III to a reverse complemen-
tary element I (construct #16). Transgenic embryos gen-
erated from both constructs showed transgene expression
in the AER, 75% (3/4) for construct #15 and 100% (5/5)
for construct #16 (Fig. 2) showing that reverse comple-
ments of elements I and III can functionally substitute for
each other.
Both Dlx5 and Sox11 can induce reporter gene expression
To confirm that Dlx5 and Sox11 can regulate Msx2
expression through the 55-bp enhancer, we cloned a
tetramer of the 55-bp Msx2 AER enhancer into the
luciferase reporter vector, pGL3-basic, and cotransfected
the construct together with expression vectors pcDNA-
Dlx5 and/or pcDNA–Sox11 into HeLa cells. We chose to
use HeLa cells as in preliminary experiments, these cells
showed very low basal activity without Dlx5 or Sox11
compared with DF-1, C3H10T1/2, or COS-7 cells. As
shown in Fig. 5, Dlx5 stimulates luciferase expression
threefold and Sox11 stimulates twofold. A combination of
both Dlx5 and Sox11 did not increase expression above
the level with Dlx5 alone. In additional experiments (not
shown), Dlx5 activated a construct containing only ele-
ment I, and Sox11 activated a construct containing only
element III.
The lack of cooperative stimulation of transgene ex-
pression in HeLa cells when Dlx5 and Sox11 are co-
expressed might reflect the absence of a factor binding to
element II, located between the Dlx5 and Sox11 binding
sites, which might be necessary for cooperative activation
of the reporter gene or that other non-DNA bindingproteins may cooperate with Dlx5 or Sox11 to activate
transcription through elements I and III. We tested the
potential for two Dlx interacting proteins, Dlxin1 (Masuda
et al., 2001) and GRIP (Yu et al., 2001), to increase Dlx5
stimulation of transcription from the AER enhancer or
facilitate cooperative activation by Dlx5 and Sox11, but
neither increased transcription in the presence of Dlx5 nor
both Dlx5 and Sox11 (data not shown). Since element II
matches well with the POU consensus binding site, we
tested whether Brn1, a POU domain containing transcrip-
tion factor reported to synergistically cooperate with
Sox11 to increase transcription (Kuhlbrodt et al., 1998),
could further enhance the activation of our Msx2/luciferase
reporter. No increase in transcription was observed in
these experiments.
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Multiple regulatory elements constitute the Msx2 AER
enhancer
We have shown that there are three separate elements in
the 55-bp region studied in this work that are required for
expression in the AER of a transgene containing a tetramer
of these regulatory elements. In addition, based on our
findings, we hypothesize that additional enhancer elements
outside of the 55-bp enhancer region also contribute toMsx2
AER expression in chicken, mouse, and human. Our studies
showing that the frequency of generation of AER expressing
embryos is much higher for constructs containing extensive
intact 5V sequence such as construct #17 (11/12) compared
with constructs such as #1 (4/7) suggest that additional AER
enhancer elements are present upstream of the 55-bp region
of focus in the current work.
Studies of the mouse and human genes support the
hypothesis that elements outside of the conserved 55-bp
region contribute importantly to AER enhancer activity. We
have shown that the conserved regions of the mouse and
human Msx2 genes corresponding to the 55-bp chicken
sequence do not function as efficiently as the chicken
enhancer sequence giving expression in 50% (mouse) and
20% (human) of embryos compared to the 93% observed
with the chicken sequence. Since the endogenous Msx2 is
known to be consistently expressed in the AERs of develo-
ping embryos, the above findings suggest that there must be
additional AER enhancer elements in the mouse gene
located outside of the 55-bp region that compensate for
the reduced effectiveness of the mouse conserved region.
This is consistent with the findings of Liu et al. (1994) who
showed that constructs containing a 300-bp region of mouse
Msx2 sequence, including the corresponding conserved
region, did not direct AER expression in the five embryos
examined. However, including an additional less conserved
139-bp region immediately upstream of the highly con-
served region in the mouse Msx2 gene resulted in two of the
four lines expressing the reporter in the AER. A comparison
of the 139-bp region with chicken sequence from the
corresponding region showed less than 40% sequence
identity between the mouse and chicken sequence.
Do transcription factors other than Dlx5 and Sox11 regulate
AER expression of Msx2 through elements I and III in vivo?
Our results show that elements I and III are necessary for
AER expression of the reporter gene, and based on our one-
hybrid studies, EMSA, cotransfection, and the pattern of
gene expression in the AER, Dlx5, and Sox11 are strong
candidates for regulating Msx2 through elements I and III,
respectively. Although only Dlx5 and Sox11 were isolated in
the one-hybrid screens with elements I and III, respectively,
other transcription factors are expressed in the AER, which
could also bind to these elements, including other Dlxproteins, Msx2, En2, other homeodomain proteins, and
other Sox proteins. We have shown by EMSA analysis that
Dlx3 and Dlx6 are also able to bind to element I (not
shown), and in previous work from our lab, Msx2 and Dlx5
have been shown to be able to bind to element III (Pan et al.,
2002). Furthermore, since mouse Msx2 is still fully
expressed in the AERs of forelimbs of Dlx5/6 homozygous
null mice (Robledo et al., 2002), Dlx5 cannot be the only
element I-binding factor required for the expression of Msx2
in the AER.
Intriguingly, after E11.5, the hindlimbs of Dlx5/6 homo-
zygous null mice express Msx2 only in the anterior and
posterior regions of the AER and not in the central regions
of the AER. This pattern is very similar to that we observed
for the h-gal reporter in the forelimbs of mice carrying
reporter construct #3 (see Fig. 1). Construct #3 contains
conserved element I, the element that selected Dlx5 in one-
hybrid screening, plus approximately 350 bp of sequence
upstream of element I. A possible explanation for the loss of
Msx2 expression in the central region of the AER in the
hindlimbs of Dlx5/6 homozygous null mice might be that
Msx2 expression in the AER requires a threshold level of
Dlx transcription factor activity, and that due to inactivation
of Dlx5 and Dlx6 genes, the total Dlx activity drops below
this threshold in the central region of the AERs of the
hindlimbs of mice deficient for Dlx5 and Dlx6. Although the
forelimbs might have a similar variation in Dlx activity
across the AER, the overall level of Dlx activity of the
forelimbs might be higher and thus remain above the
required threshold for Msx2 expression. Although reporter
construct #3 contains element I that is responsive to Dlx
transcription factors, the loss of elements II and III might
sufficiently weaken the AER enhancer so that it shows
transcription activity only in the anterior and posterior
regions of the forelimb AER where, by our hypothesis,
the total Dlx activity might be highest. An alternative
explanation for the observations with construct #3 could
be that enhancers that are specific for the anterior and
posterior regions of the AER are within the sequences
present in this construct, and sequences necessary for
expression of Msx2 in the central region of the AER are
absent from this region and are provided by elements II and/
or III.
Factors other than Dlx5 and Sox11 are needed to limit Msx2
expression to the AER and to direct Msx2 expression to the
AER
We know, based on the co-expression of endogenous
Dlx5 and Sox11 genes in regions of the limb where our
Msx2/reporter constructs are not expressed, that these two
transcription factors alone are not sufficient to restrict
expression of these constructs to the AER, suggesting that
other regulatory mechanisms/factors may cooperate with
these two transcription factors. One possibility is that a
factor binding to sequence element II provides the specifi-
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#11) that this element is also important in directing reporter
activity to the AERs of transgenic mice. Additional cofac-
tors that interact with either Dlx5 or Sox11 could also
provide AER specificity. The presence of the three sequence
elements (I, II, and III) near in the 55-bp conserved region
suggests the possibility that multiple factors associate with
this region, form a complex, and cooperate synergistically to
regulate Msx2 expression in the AER.
Is there a common AER enhancer present in other genes
expressed in the AER?
Partial characterization of regions responsible for AER
expression has been reported for several different genes
including mouse FGF4 (Fraidenraich et al., 1998), mouse
and zebrafish Dlx1/2 and Dlx5/6 (Ghanem et al., 2003;
Zerucha et al., 2000), and Xenopus and mouse Dlx3/4(7)
(Morasso et al., 1995; Sumiyama and Ruddle, 2003).
Examination of these various reports shows that there are
some characteristics in common between these various
genes. Sequences matching the Dlx consensus binding
sequence are present in the genomic regions identified as
being responsible for AER expression in all of these genes,
although in none of the cases have the Dlx binding sites
been specifically examined for their role in AER expression.
Within the intergenic region of the Dlx5/6 cluster, there is a
region conserved among zebrafish, mouse, human, and
chicken that is similar to the chicken Msx2 55-bp AER
enhancer. It contains three sites with high similarity to
elements I, II, and III (6/7, 5/6, and 6/7 identical nucleotides,
respectively) and with similar spacing, although the sequen-
ces between the putative conserved elements showed only a
low level of identity with the corresponding chicken Msx2
sequence (14/35). Various fragments varying in length from
130 to 473 bp containing this region from zebrafish or
mouse have been characterized in reporter transgenes in
transgenic mice and expression was observed in the AER
with two of the constructs containing the region
corresponding to the chicken 55-bp Msx2 AER enhancer
although only in a small fraction of mice (1/5 for the 130-bp
sequence within the ZI56i (nt 187–316) from the zebrafish
Dlx5/6 cluster (Zerucha et al., 2000) and 1/17 for region
MI56i from the mouse Dlx5/6 cluster (Ghanem et al.,
2003)). Dlx protein can upregulate transcription of a trans-
gene containing the conserved intergenic sequences in
transient cotransfection assays in cultured cells, and muta-
tion of the site corresponding to elements I in this fragment
greatly reduced Dlx2 stimulation of reporter expression
(Zerucha et al., 2000). Expression of a reporter transgene
containing the full intergenic region was reduced in mice
lacking both Dlx1 and Dlx2 showing that Dlx has a role in
expression of Dlx5/6 in vivo. More than one region of the
Dlx5/6 (and Dlx1/2) genomic sequences can direct AER
expression. Each of the two intergenic regions of the Dlx5/6
complex (and of the Dlx1/2 intergenic region) is able todrive AER transgene expression (Ghanem et al., 2003).
Transgene constructs containing different AER regulatory
regions from the same gene differ dramatically in the
fraction of mice that express the reporter in the AER. The
MI12b and MI56ii regions appear to be better AER
enhancers than MI12a and MI56i as reporter constructs
containing MI12b and MI56ii were expressed in 8/8 and
3/5 embryos, respectively, whereas constructs with MI12a
and MI56i were expressed in 1/7 and 1/14 embryos (Gha-
nem et al., 2003). Although Fgf4 and Dlx1/2 and Dlx3/4
genes have potential Dlx binding sites in the regions
identified as having the ability to drive AER expression,
these regions do not contain sequences with high similarity
to the entire 55-bp region.
Overall, these results are consistent with some of our
conclusions regarding regulation of the chicken Msx2 gene
in the AER. In particular, Dlx genes are likely to play a
significant role in regulating multiple genes expressed in the
AER, and it is likely that multiple AER regulatory sites are
present in each gene that cooperate to regulate gene expres-
sion in the AER.Acknowledgments
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